Monoclonal antibodies to hepatocyte growth factor
CA 2563080 C · Owner: Galaxy Biotech, Llc · Inventors: Kim, Kyung Jin; Su, Yi-Chi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention is directed toward a neutralizing monoclonal antibody to hepatocyte growth factor, a pharmaceutical composition comprising same and , methods of treatment comprising administering such a pharmaceutical composition to a patient, such as for inhibiting glioblastoma.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 13, 2004 and granted January 27, 2015. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended August 13, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 13, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.